What Matters to You? (Assert)

February 7, 2020 updated by: Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse

What Matters to You? How to Strengthen Adolescent User Involvement in Primary Mental Health Services With Systematic Idiographic Assessment

Procedures for systematic user involvement in primary mental health services are lacking, and several adolescents are dissatisfied with their opportunities to influence the service provided. The research on the effects of user involvement is scarce, especially regarding user involvement for children and adolescents. Hence, we suggest introducing an idiographic assessment tool in a selection of Norwegian primary mental health services. Idiographic assessment is a way of measuring psychological constructs, by using tools specifically adapted for each individual respondent.

This protocol describes the implementation and evaluation of a user involvement tool called 'Assert', in Norwegian primary mental health services. Assert is a simple tool where the adolescents themselves decide the goals or themes that they would like to address in collaboration with their service provider. Assert is scored each time the adolescent and the service provider meet, to monitor progress toward the goal. A randomised controlled trial design is proposed for this study. Assert will be implemented in 5-10 Norwegian municipalities, and will include 250 participants between 12 and 23 years. The objective of the study is to examine the relationship between Assert and perceived user involvement. Are idiographic measures an adequate way to operationalise user involvement on an individual level? And if so, can user involvement (i.e. Assert) have an effect on quality of life and mental health in adolescents? And lastly qualitative analyses of the adolescents' themes and goals will be conducted to explore what matters to the adolescents that visit primary mental health services in Norwegian municipalities.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hønefoss, Norway
        • Ringerike kommune
      • Kongsberg, Norway
        • Kongsberg kommune
      • Lillestrøm, Norway
        • Skedsmo kommune
      • Lørenskog, Norway
        • Lørenskog kommune
      • Mysen, Norway
        • Eidsberg Kommune
      • Oslo, Norway
        • Bydel Søndre Nordstrand
      • Oslo, Norway
        • UngArena
      • Tønsberg, Norway
        • Familiehuset Adler
      • Ulefoss, Norway
        • Nome kommune
      • Våler, Norway
        • Våler kommune
      • Ål, Norway
        • Ål kommune

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 23 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adolescents between 12 and 23 years, with behavioural, emotional, and psychosocial problems

Exclusion Criteria:

  • severe psychopathological disorders
  • severe drug addiction
  • intellectual disabilities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention
The Assert-method will be used in the counselling of adolescents with mental health problems
The Assert-method is a counselling method used to assess and systematically follow up the individual adolescents' perceived needs.
NO_INTERVENTION: Control
Treatment as usual, i.e. tha Assert-method will not be used in the counselling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Strengths and difficulties questionnaire (SDQ)
Time Frame: One year
One year
Inventory of Life Quality in Children and Adolescents (ILC)
Time Frame: One year
One year
Multidimensional Health Locus of Control (MHLC)
Time Frame: One year
One year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Assert measurement tool
Time Frame: One year
An ideographic assessment and monitoring tool, used as a part of the Assert method
One year
User involvement questionnaire
Time Frame: One year
Perceived degree of user involvement
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Turid Suzanne Berg-Nielsen, PhD, Regional Centre for Child and Adolescent Mental Health, Eastern and Southern Norway (RBUP)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2017

Primary Completion (ACTUAL)

June 1, 2018

Study Completion (ACTUAL)

June 1, 2018

Study Registration Dates

First Submitted

January 4, 2017

First Submitted That Met QC Criteria

January 5, 2017

First Posted (ESTIMATE)

January 9, 2017

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2016/FO77493

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavioural, Emotional, and Psychosocial Problems

Clinical Trials on Assert

3
Subscribe